The authorization is specifically for those with mild-to-moderate Covid-19, who are at risk of getting much sicker... May 27
Another ANDA approval for Unichem... Nov 30
First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency... Nov 28
Alembic now has a total of 135 ANDA approvals (117 final approvals and 18 tentative approvals) from USFDA.... Nov 10
BXCL50 is indicated for the treatment of agitation associated with Delirium... Oct 27
Protagonist Therapeutics has previously received orphan drug designation for the treatment of polycythemia vera from US FDA... Oct 22
U.S. FDA grants fast track designation for ASP0367/MA-0211, a selective PPARδ modulator being developed for the treatment of primary mitochondrial myopathies ... Oct 21
Ezra's Prostate AI is the first to ever be cleared by the FDA for prostate and lesion segmentation using AI ... Oct 20
First FDA approved antibody treatment for Ebola... Oct 19
Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ... Oct 03
The study will enrol up to 40 patients into two cohorts, randomized 1:1 to receive the active study drug plus standard treatment or placebo... Sep 29
PMM2-CDG is a debilitating rare disease causes multiple organ failure and severe disability, resulting in approximately 20% mortality in the first four years of ... Sep 26
... Sep 23
Receives ANDA for Lisinopril and Acylovir tablets... Sep 21
Cervical cancer detection gets new tests for early diagonosis... Sep 18
Oral Covid vaccine gains ground... Sep 18
End-to-end solution and components offer flexibility to testing facilities, meeting high-volume demand and significantly boosting global testing capacity ... Sep 16
The FDA-approved strength for both COPD and asthma is fluticasone furoate / umeclidinium / vilanterol 100/62.5/25mcg. ... Sep 14
Major breakthrough for treatment of Nasopharyngeal Carcinomar ... Sep 11
-Advertisements-
Thursday, April 25, 2024
